IBM and Agilent are bringing two technologies together to create an informatics system designed to help researchers collaborate through the entire discovery process so they can design better drugs and get them to market faster. The two technologies are IBM’s DiscoveryLink data integration software and Agilent’s new Synapsia Informatics Workbench software.
Data integration boosts drug research
We'd love to hear your opinion about this or any other story you read in our publication. Click this link to send me a note →
Jim Love, Chief Content Officer, IT World Canada
Our experienced team of journalists and bloggers bring you engaging in-depth interviews, videos and content targeted to IT professionals and line-of-business executives.